Korean J Intern Med.
1998 Feb;13(1):51-55.
Role of circulating immune complex in aspirin-sensitive asthma
- Affiliations
-
- 1Department of Allergy, Ajou University School of
Medicine, Suwon, Korea.
- 2Department of Clinical Immunology, Ajou University School of
Medicine, Suwon, Korea.
Abstract
-
BACKGROUND & OBJECTIVES: The pathogenic mechanism of aspirin-sensitive asthma
(ASA-BA) remains to be further defined. To evaluate the role of circulating
immune complex (CIC) in ASA-BA. SUBJECTS & METHODS: We measured IgG- and IgA-IC
level by ELISA using anti-C3 antibody in 33 ASA-BA patients whose sensitivity
was confirmed by lysine-aspirin bronchoprovocation test, and compared with those
of 14 allergic, 14 intrinsic asthma patients and 7 healthy controls. RESULTS:
There was no significant difference in IgG-IC level among the four groups (p >
0.05), while IgA-IC levels of aspirin-sensitive asthma were higher than those of
other groups (p = 0.0035). Patients with nasal polyp had significantly higher
IgG-IC than those without it (p = 0.02). No differences were found according to
medication and symptom scores, and presence of atopy, rhino-sinusitis, urticaria
or concurrent sensitivity to sulfite (p > 0.05). Insignificant correlation was
found between IgG-IC level and asthma duration, total IgE level, or circulating
eosinophil count. CONCLUSION: These findings suggest a possible contribution of
IgG-IC to the development of nasal polyp in ASA-BA. Further study will be needed
to clarify the role of IgA-IC in the pathogenesis of ASA-BA.